Save the date! Friday 25th October 2024, is when HCA Healthcare (NYSE: HCA) will be sharing its eagerly awaited third quarter financial results. Investors and analysts will be able to gain valuable insights into the company's financial performance as the announcement is scheduled before market open.
As per the projections made by financial experts on Wall Street, the concern is expected to announce an estimated $4.96 profit per share for the quarter. Moreover, the firm is likely to disclose a quarterly revenue of $17.54 billion.
The earnings report for the corresponding quarter in the previous year showcased a per-share income of $3.91. This considerable sum was attributed to the company's total revenue, which reached an impressive $16.21 billion during that specific quarter.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $70.91 billion. Moreover, they anticipate the company to disclose profit of $22.62 per share for the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $5.50 | +28.2% | 17.49 B | +10.3% |
| Q1 2024 | $5.36 | +8.7% | 17.34 B | +11.2% |
| Q4 2023 | $5.90 | +27.2% | 17.30 B | +11.7% |
| Q3 2023 | $3.91 | -0.5% | 16.21 B | +8.3% |
| Q2 2023 | $4.29 | +1.9% | 15.86 B | +7.0% |
| *Growth on year-over-year basis | ||||
The business has scheduled a conference call on 25th October 2024 at 10:00 AM eastern time to discuss Q3 financial results.
Wednesday's trading saw HCA Healthcare (HCA) shares hit a low of $406.33 and a high of $410.79, with a day volume of 905.40 thousand shares. The stock closed the regular trading session at $410.03, indicating 0.46 percent increase.
